The AI Eye: IBM (NYSE: $IBM) and Samsung Leverage AI and Cloud in Health Tracking Platform, Virtusa (Nasdaq: $VRTU) Collaborates with AWS (Nasdaq: $AMZN)
Point Roberts, WA and Vancouver, BC - October 30, 2019 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today's edition of The AI Eye - watching stock news, deal tracker and advancements in artificial intelligence.
Listen to today's podcast:
The #AI Eye: IBM (NYSE: $IBM) and Samsung Leverage AI and Cloud in Health Tracking Platform, Virtusa (Nasdaq: $VRTU) Collaborates with AWS (Nasdaq: $AMZN)
Today's Column - The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence
Stocks discussed: (NYSE:IBM) (NasdaqGS:VRTU) (NasdaqGS:AMZN)
IBM (NYSE:IBM) and Samsung Electronics (KSE:005930) have announced a new joint platform leveraging IBM Cloud and AI capabilities, and Samsung's mobile offerings. The platform will aid governments and enterprises in tracking the health vitals of workers - including heart rate and physical activity - determining if the worker in question needs assistance. Martin Schroeter, senior vice president of global markets from IBM, commented:
"IBM continues to bring leading cloud and AI capabilities with deep industry expertise to our enterprise clients. Together, IBM and Samsung will use the power of IBM Cloud, 5G, AI and edge computing to enable our clients to leverage these advanced technologies to have greater impact on the way people work, shop and protect their health and families."
Virtusa Corporation (NasdaqGS:VRTU) is advancing medical research using AI and machine learning in collaboration with The University of Texas Health Science Center at Houston (UTHealth), Cardinal Health, and Amazon Web Services (AWS), a subsidiary of Amazon (NasdaqGS:AMZN). Initial focus of the project will be on "finding the best treatment and management strategies for subarachnoid hemorrhage (SAH) and diabetes based on health care data and computer simulations". Anthony Lange, senior vice president, Life Sciences, Virtusa, explained:
"Life science companies must address how to seize the upside of disruption in today's transformation age. Future value in life science is driven by innovation that focuses on outcomes with a high degree of personalization and is fueled by unlocking the power of simulated data. At Virtusa, we recognize the critical importance of collaboration in advancing AI technologies to create intelligent solutions that make lives better and businesses more efficient. As data becomes the fuel driving technological and economic growth, a fundamental challenge is how to quantify the value of data in algorithmic predictions and decisions. At Virtusa, we leverage our deep industry and technical expertise to define solutions that make it easier for organizations to benefit from AI. We are very excited to be taking such problems head-on along with UTHealth on our vLifeTM Platform."
Healthcare Chatbots Market to Hit $703.2 Million by 2025
A report from Research and Markets finds that the global Healthcare Chatbots market will reach $702.3 million by 2025 with a compound annual growth rate (CAGR) of 25.1 percent in the forecast period. An excerpt from the report description reads:
Optimum internet connectivity and rising adoption of smart devices, limited availability to council huge patient population, technology advancement in artificial intelligence, chatbots to reduce the healthcare cost, and increasing demand of virtual health assistance are the key factors driving the growth of the global healthcare chatbots market. However, factors such as data privacy concern, lack of expertise for chatbot development, and lack of awareness and misconception are hindering the growth of this market.
Sam Mowers, Investorideas.com
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.
The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
800 665 0411